Your shopping cart is currently empty

RFRP-3(human) acetate, a human GnIH peptide homolog, is a potent inhibitor of gonadotropin secretion by inhibiting Ca2+ mobilization. RFRP-3(human) acetate is a NPFF1 receptor agonist, it inhibits forskolin-induced production of cAMP with an IC50 of 0.7 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $48 | In Stock | In Stock | |
| 5 mg | $109 | In Stock | In Stock | |
| 10 mg | $163 | In Stock | In Stock | |
| 25 mg | $269 | In Stock | In Stock | |
| 50 mg | $395 | In Stock | In Stock | |
| 100 mg | $563 | In Stock | In Stock |
| Description | RFRP-3(human) acetate, a human GnIH peptide homolog, is a potent inhibitor of gonadotropin secretion by inhibiting Ca2+ mobilization. RFRP-3(human) acetate is a NPFF1 receptor agonist, it inhibits forskolin-induced production of cAMP with an IC50 of 0.7 nM. |
| In vitro | RFRP-3(human) acetate efficiently inhibits forskolin-induced production of cAMP with an IC50 of 0.7 nM. Scatchard-plot analysis shows that 125I-labelled hRFRP-3 has a single class of high-affinity binding sites for the membrane fractions of CHO cells expressing rat OT7T022, the Kd value and the Bmax values are 0.19 nM and 1.3 pM, respectively. RFRP-3(human) acetate specifically stimulate cells transfected with a new orphan 7TMR, OT7T022, it binds to OT7T022 as a specific ligand with high affinity (Kd= 0.19 nM)[1]. |
| Molecular Weight | 1029.19 |
| Formula | C47H76N14O12 |
| Smiles | CC(C)C[C@@]([H])(C(N1CCC[C@]1(/C(O)=N/[C@@]([H])(CCC(O)=N)/C(O)=N/[C@@]([H])(CCCNC(N)=N)/C(O)=N/[C@@]([H])(CC2=CC=CC=C2)C(O)=N)[H])=O)/N=C([C@]([H])(CC(O)=N)/N=C([C@@]3(CCCN3C([C@]([H])(C(C)C)N)=O)[H])\O)\O.CC(O)=O |
| Relative Density. | no data available |
| Sequence | H-Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2 |
| Sequence Short | VPNLPQRF |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.